抑制了微管调节的胰腺胰岛素分泌
Salvatore P Mangiafico1, Qing-Zhang Tuo2, Xiao-Lan Li2
1Department of Medicine, Austin Hospital, University of Melbourne, Heidelberg, VIC, 3084, Australia.
Molecular psychiatry
|September 22, 2023
概括
蛋白主要用于阿尔茨海默病,在调节胰岛素分泌和葡萄糖平衡中起着关键作用. 降低糖尿病模型中的水平改善了葡萄糖控制,表明是阿尔茨海默氏症和2型糖尿病的治疗标.
科学领域:
- 神经科学是一个神经科学.
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
背景情况:
- 蛋白主要在大脑中研究其在阿尔茨海默氏症 (AD) 中的作用.
- 蛋白也在胰腺中表达,可能会影响葡萄糖代谢.
- 的生理功能,特别是在非神经元组织中,仍然在很大程度上未被探索.
研究的目的:
- 研究胰腺在调节葡萄糖刺激胰岛素分泌 (GSIS) 中的作用.
- 探索,2型糖尿病 (T2DM) 和阿尔茨海默病之间的潜在联系.
- 确定tau作为潜在的AD和T2DM的共同治疗标.
主要方法:
- 从T2DM患者的胰腺β岛细胞中研究了tau水平.
- 利用细胞系,多索菲拉和小鼠模型 (db/db) 来研究tau操纵对胰岛素分泌和葡萄糖平衡的影响.
- 在糖尿病小鼠模型中进行药理和遗传抑制.
- 研究了微管组合抑制对胰岛素分泌的影响.
- 在健康对照组和AD患者中,血清蛋白水平与血糖相关.
主要成果:
- 胰腺对于调节胰岛素分泌和维持葡萄糖平衡至关重要.
- 在T2DM患者的β岛屿细胞中观察到水平升高.
- 功能丧失在各种模型中增强了胰岛素分泌.
- 在糖尿病小鼠中抑制陶氨酸通过促进胰岛素分泌来使葡萄糖水平正常化.
- 微管组装的药理抑制模仿了抑制的效果.
- 在健康人群中,血清与血糖有积极的相关性,但在阿尔茨海默病患者中没有这种相关性.
结论:
- 胰腺中的陶蛋白是胰岛素分泌和葡萄糖代谢的关键调节者.
- 异常的陶水平与2型糖尿病有关.
- 向陶为阿尔茨海默病和2型糖尿病提供了一个有前途的治疗策略.
相关概念视频
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.3K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.3K
Insulin Secretory Vesicles
5.0K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
5.0K
Hormones Regulating Blood Glucose
3.5K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.5K
Insulin: The Receptor and Signaling Pathways
1.3K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.3K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K


